Board of Directors

The composition of Novozymes' Board of Directors following the Annual Shareholders' Meeting on February 22, 2017.

  • joergen
    Jørgen Buhl RasmussenBorn 1955.

    Chairman of the Board since 2017. Adjunct Professor at Copenhagen Business School. Member of the Audit Committee. Chairman of the Nomination and Remuneration Committee. Member of the Board since 2011. Elected for one year at a time.

    Board positions
    Chairman: F. Uhrenholt A/S
    Member: IFC Europe A/S, Human Practice Foundation, Advisory Board of Axcel

    Special competencies
    International business and management experience, specifically within sales, marketing, branding and acquisitions. Experience in finance and accounting matters.

  • agnete
    Agnete Raaschou-NielsenBorn 1957.

    Vice Chairman of the Board since 2017. Member of the Audit Committee. Member of the Nomination and Remuneration Committee. Member of the Board since 2011. Elected for one year at a time.

    Board positions
    Chairman: Arkil Holding A/S, Brdr. Hartmann A/S, Danske Invest
    Member: Aktieselskabet Schouw & Co., Danske Invest Management A/S

    Member of Audit Committees

    Aktieselskabet Schouw & Co.

    Special competencies

    Expertise within business development and acquisitions, macroeconomics and intellectual property rights. Experience in finance and accounting matters.

  • lars
    Lars GreenBorn 1967.

    Senior Vice President, Finance & Operations, Novo Nordisk Inc. Chairman of the Audit Committee. Member of the Board since 2014. Elected for one year at a time.

    Special competencies
    In-depth knowledge of the Novo Group’s business, international experience from managing global biotechnology and biopharma companies, and financial and accounting expertise.

  • kasim
    Kasim KutayBorn 1965.

    President & CEO, Novo A/S. Member of the Board since 2017. Elected for one year at a time.

    Board positions
    Member: Novo Nordisk A/S


    Special competencies
    Broad experience within biotechnology, and mergers and acquisitions. Experience in finance and accounting matters.
  • kim
    Kim StrattonBorn 1962.

    Head of International Commercial, Shire International GmbH. Member of the Nomination and Remuneration Committee. Member of the Board since 2017. Elected for one year at a time.

    Special competencies
    Broad international commercial experience within sales and marketing, emerging markets, innovation pipeline management and sustainability.

  • mathias
    Mathias UhlénBorn 1954.

    Professor at the Royal Institute of Technology (Sweden) and the Technical University of Denmark (DTU).  Member of the Board since 2007. Elected for one year at a time.

    Board positions

    Chairman: Atlas Antibodies AB, Antibodypedia AB
    Vice Chairman: Affibody Medical AB
    Member: Alligator AB, Bure Equity AB, Woodheads AB

    Special competencies

    Broad experience in research and biotechnology.

  • lena_bech
    Lena Bech HolskovBorn 1967.

    Safety Adviser. Employee representative. Member of the Board since 2013. Elected for four years at a time.

  • anders_hentze
    Anders Hentze KnudsenBorn 1959.

    Senior Operator. Employee representative. Member of the Board since 2013. Elected for four years at a time.

  • lars_bo_koppler
    Lars Bo KøpplerBorn 1962.

    Technician. Employee representative. Member of the Board since 2010. Elected for four years at a time.
     
    Employee elected member of the board of Novo Nordisk Foundation since 2014. Elected for a four year period.